insights_auto
Perspektīva: 87.5% garā pozīcija·0.0% īsā pozīcija
Pāriet uz analīzichevron_right
TEVA:TLV
Teva Pharmaceutical Industries
12 940,00 ILA
arrow_upward
+1,57%(+200,00) 1 d.
14. okt., 17:29:42 GMT+3 · ILA
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: TEVA…
Atvērt
12 730,00 ILA
Augsta
12 940,00 ILA
Zema
12 620,00 ILA
Tirgus kapitalizācija
46,68 mljrd.
Vid. apjoms
1,08 milj.
Apjoms
971,42 tūkst.
Cenas/peļņas attiecība
70,10
Augstākā 52 ned.
12 940,00 ILA
Zemākā 52 ned.
6 207,00 ILA
Peļņa uz vienu akciju
1,85 ILA
Apgrozībā esošās akcijas
1,17 mljrd.
Darbinieku skaits
32 tūkst.
Atvērt
12 730,00 ILA
Augsta
12 940,00 ILA
Zema
12 620,00 ILA
Tirgus kapitalizācija
46,68 mljrd.
Vid. apjoms
1,08 milj.
Apjoms
971,42 tūkst.
Cenas/peļņas attiecība
70,10
Augstākā 52 ned.
12 940,00 ILA
Zemākā 52 ned.
6 207,00 ILA
Peļņa uz vienu akciju
1,85 ILA
Apgrozībā esošās akcijas
1,17 mljrd.
Darbinieku skaits
32 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
ad-hoc-news.de
·
pirms 13 stundām
Barclays keeps Buy rating for Teva stock at USD 42.00
ad-hoc-news.de
·
pirms 1 dienas
JPMorgan raised target for Teva stock to USD 50.00
MarketBeat
·
pirms 2 dienām
Teva Pharmaceutical Industries (NYSE:TEVA) Stock Price Target Raised at JPMorgan Chase & Co.
Yahoo Finance
·
pirms 2 dienām
TEVA Stock Alert: What to Know as Teva Therapeutics' Scores FDA Approval for Schizophrenia Treament
Profils
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States.
Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America.
Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs. Wikipedia
Par “Teva Pharmaceutical Industries”
ĢenerāldirektorsRichard Francis
Darbinieki32 tūkst.
Dibināšanas datums1944. gada 13. febr.
Galvenais birojs-
Sektors-
Tīmekļa vietneteva.co.il